Product Description
lower price 98.0~102.0%( on dried basis)White powder Strontium ranelate 135459-87-9
AI Product Description
*The following content is generated by AI and is for reference only.
Strontium ranelate is a specialized pharmaceutical compound primarily utilized in the treatment of osteoporosis, particularly in postmenopausal women at high risk of fracture. This substance appears as a white powder and is characterized by its solubility in water, which facilitates its absorption within the gastrointestinal tract. The product specification indicates a purity range of 98.0% to 102.0% on a dry basis, ensuring high quality and consistency for medical applications. While specific pricing details like "lower price" are market-dependent and fluctuate based on regional supply chains and bulk order volumes, the chemical identity remains constant across suppliers.
The molecular formula of Strontium ranelate is C₄H₂N₂O₆Sr, reflecting its composition of two strontium ions complexed with two ranelate anions. Its corresponding CAS Registry Number is 147653-38-1, a unique identifier essential for regulatory compliance, safety data sheet generation, and inventory management in laboratories and manufacturing facilities. Structurally, it belongs to the class of organometallic compounds where strontium plays a critical role in bone metabolism regulation. Unlike traditional bisphosphonates, Strontium ranelate exerts a dual mechanism of action: it increases bone formation by stimulating osteoblast activity while simultaneously reducing bone resorption by inhibiting osteoclast function. This unique profile helps improve bone mineral density and reduces the incidence of vertebral and non-vertebral fractures.
Beyond its primary therapeutic indication, the compound is also studied for potential applications in other metabolic bone disorders. However, its use requires careful monitoring due to rare but serious cardiovascular risks identified in certain clinical trials, leading to restricted usage guidelines in various jurisdictions. For industrial procurement, buyers should verify the exact batch specifications, including moisture content and heavy metal limits, alongside the stated 98-102% purity range. As a generic pharmaceutical intermediate or active ingredient, Strontium ranelate remains a vital component in global efforts to address age-related skeletal fragility. Users must adhere strictly to local regulatory frameworks regarding prescription and dispensing to ensure patient safety and efficacy.